Thank you for sharing!

Your article was successfully shared with the contacts you provided.
A lawyer for a fired Johnson & Johnson employee says manufacturing practices were unsafe at one of the company’s Puerto Rican plants and may be causing health risks. The plant in Manati manufactures Eprex, used in Europe and Canada to raise levels of red blood cells in people undergoing kidney dialysis or suffering from anemia caused by chemotherapy. Hector Arce, a boiler operator for 12 years at the plant, alleges in his lawsuit that he was unjustly fired when he refused to falsify documents before an inspection as requested by supervisors. Johnson & Johnson denies the charge. “Reproducing a biological product is like reproducing a snowflake,” said Arce’s lawyer, Juan Saavedra Castro, by telephone Friday. “This drug is so sensitive, you need to be completely accurate” in maintaining equilibrium in the production process. He argued that evidence in his client’s case shows otherwise. Arce is seeking an undetermined amount in damages over his 1999 firing from the Ortho Biologics plant, which is a subsidiary of Johnson & Johnson. The lawyer said the U.S. Food and Drug Administration began a criminal investigation into the plant after learning of Arce’s civil lawsuit. On the New York Stock Exchange, J&J shares dropped 15.9 percent, or $7.88 a share, to close Friday at $41.85. Johnson & Johnson insisted the product is safe. “We have conducted our investigations and confirmed that the integrity of the product has not been compromised,” the New Brunswick, N.J.-based company said in a statement Friday. A report in The New York Times Friday said health officials have recently found an increasing number of Eprex users have developed pure red cell aplasia, a rare condition in which the body can lose its ability to produce red blood cells, leaving patients dependent on blood transfusions to survive. Arce was responsible for monitoring the boiler and recording levels of saline, oxygen and other elements in the water, the lawsuit says. He claims supervisors told him more than 100 times between 1996 and 1999 to falsify records documenting those levels and to sign on behalf of other employees. Arce said he was fired in 1999 before an FDA inspection because he refused his supervisor’s commands to lie to FDA agents. Johnson & Johnson said Arce was a utilities worker with no involvement in the making of Eprex, and said he was fired in 1999 for dishonesty and violations of company procedures. “Our investigation of the employee’s allegations confirm that the integrity of our product has never been compromised and there is no connection between the allegations and the occurrence of (pure red cell aplasia),” the company said. Copyright 2002 Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 1 article* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.